Medincell SA
PAR:MEDCL

Watchlist Manager
Medincell SA Logo
Medincell SA
PAR:MEDCL
Watchlist
Price: 17.8 EUR -0.56% Market Closed
Market Cap: 517.6m EUR
Have any thoughts about
Medincell SA?
Write Note

Medincell SA
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medincell SA
Cost of Revenue Peer Comparison

Comparables:
SAN
IPN
VETO
VIRP
BOI

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Medincell SA
PAR:MEDCL
Cost of Revenue
-€2.3m
CAGR 3-Years
-16%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Sanofi SA
PAR:SAN
Cost of Revenue
-€18.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ipsen SA
PAR:IPN
Cost of Revenue
-€618m
CAGR 3-Years
-11%
CAGR 5-Years
-5%
CAGR 10-Years
-7%
Vetoquinol SA
PAR:VETO
Cost of Revenue
-€275.1m
CAGR 3-Years
-6%
CAGR 5-Years
-7%
CAGR 10-Years
-5%
Virbac SA
PAR:VIRP
Cost of Revenue
-€450.3m
CAGR 3-Years
4%
CAGR 5-Years
1%
CAGR 10-Years
-2%
Boiron SA
PAR:BOI
Cost of Revenue
-€130.8m
CAGR 3-Years
-5%
CAGR 5-Years
0%
CAGR 10-Years
0%

See Also

What is Medincell SA's Cost of Revenue?
Cost of Revenue
-2.3m EUR

Based on the financial report for Mar 31, 2024, Medincell SA's Cost of Revenue amounts to -2.3m EUR.

What is Medincell SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-18%

Over the last year, the Cost of Revenue growth was 34%. The average annual Cost of Revenue growth rates for Medincell SA have been -16% over the past three years , -18% over the past five years .

Back to Top